Osteoporosis: assessing and managing patients at low, high, and very high risk
Dr David Stephens introduces a consensus guideline to assist primary care in the assessment, management, and treatment of osteoporosis
Pregnancy and rheumatic diseases: best practice and prescribing considerations
Professor Ian Giles and Professor Caroline Gordon describe best practice in the care of women of child-bearing age with inflammatory rheumatic diseases before, during, and after pregnancy
Top tips: joint pain
Dr Louise Warburton offers 10 top tips on the diagnosis and management of joint pain in primary care
Osteoporosis: target treatment on the basis of fracture risk
Dr David Stephens summarises new recommendations from the updated SIGN guideline on the management of osteoporosis and prevention of fragility fractures
Key learning points: physical activity in osteoporosis
Sarah Leyland, Virginia Wakefield, and Dr Zoe Paskins highlight six essential points from the Royal Osteoporosis Society guidance on physical activity and exercise for people with osteoporosis
Test and reflect
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Educational resources
Patient consultation guide—supporting the management of patients with osteoporosis
This promotional supplement has been commissioned by Amgen and developed in partnership with Guidelines in Practice. Information for UK healthcare professionals only.
View Prolia® (denosumab) prescribing and adverse event reporting information
GB-PRO-0222-00034 March 2022
Disease-modifying anti-rheumatic drugs (DMARDS) guidelines: a focus on methotrexate guidance in clinical practice
Information intended for UK healthcare professionals only. This webinar was initiated and commissioned by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
View Methofill® (methotrexate) pre-filled injector and pre-filled syringe prescribing information and adverse event reporting information here
View the Summary of Product Characteristics for Folic Acid 5mg Tablets; Legal Cat POM; NHS List price 90p
UK-02645
Date of preparation: September 2021
The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document
Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d Date of preparation: August 2021